Target intelligence / Profile preview

Viral RNA genome (vRNA)

Target
vRNA
Molecular classification
Other
01

Overview

The viral RNA genome is the complete set of genetic instructions for an RNA virus, existing as either single-stranded (ssRNA) or double-stranded (dsRNA) molecules (NCBI, 2002). It serves as a critical template for the translation of viral polyproteins and the replication of new genomic strands by viral polymerases (Nature Reviews Drug Discovery, 2017). Many viral RNA genomes contain intricate structural elements, such as internal ribosome entry sites (IRES) or 3' untranslated regions (UTRs), which recruit host and viral factors to initiate protein synthesis and regulate stability (PubMed, 2021). As the core component of viral pathogens like SARS-CoV-2, HIV-1, and Hepatitis C virus, the RNA genome is a primary driver of infectious diseases and associated inflammatory responses (WHO, 2023). Therapeutic interventions targeting the viral RNA genome include nucleoside analogs that act as chain terminators or induce error-prone replication, leading to lethal mutagenesis (PubChem, 2024). Furthermore, modern approaches utilize antisense oligonucleotides (ASOs) and RNA interference (RNAi) to directly bind and catalyze the degradation of the viral genome, thereby halting the infection cycle (NIH, 2022).

Other names
Viral RNAGenomic RNAvRNAViral ribonucleic acid
02

Mechanism of action

Lethal mutagenesis, premature chain termination, RNA interference (RNAi), and antisense-mediated degradation or translation blocking (PubMed, 2021; Nature Reviews Drug Discovery, 2017).

03

Biological functions

Other
04

Disease associations

Infection
05

Safety considerations

Off-target binding to host RNA (Nature Reviews Drug Discovery, 2017)Innate immune activation via TLR7/8 (NIH, 2022)Emergence of drug-resistant mutations (PubMed, 2023)Delivery to target tissues (PubMed, 2021)
06

Interacting drugs

Molnupiravir

5 more in the full profile.

07

Biomarkers

Viral load (RT-qPCR) (CDC, 2023)Viral RNA titers (WHO, 2023)Genomic sequence variants (NCBI, 2024)

Beyond the preview

Go deeper on Viral RNA genome (vRNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Viral RNA genome (vRNA).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call